欧洲基线系列香料标记斑贴试验2016年更新:筛查效度不足
该研究回顾性分析2015–2016年湿疹患者斑贴试验记录,评估欧洲基线系列香料标记对26种需标签标注香料物质的筛查效度。结论认为现行四种香料标记已不足以筛查香料过敏。
要点
- 现行欧洲基线系列香料标记筛查香料过敏的敏感性不足。
- 氧化芳樟醇和氧化柠檬烯是最常见的阳性香料变应原。
核心结论
- 鉴于香料过敏趋势演变,使用FMI、FMII、秘鲁香脂和羟基异己基3-环己烯甲醛进行斑贴试验已不足以筛查香料过敏。
研究设计与样本
- 回顾性审查2015–2016年所有接受欧洲基线系列扩展个体香料物质斑贴试验的湿疹患者记录。
临床怎么用
- 临床筛查香料过敏时,不应仅依赖欧洲基线系列四种香料标记,需扩展测试个体香料物质。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fragrance contact allergy is common and is currently screened for using the following European baseline series fragrance markers: fragrance mix (FM)I, FMII, Myroxylon pereirae and hydroxyisohexyl 3-cyclohexene carboxaldehyde. OBJECTIVES: To investigate the validity of patch testing using these fragrance markers in detecting fragrance allergy to 26 individual fragrance substances for which cosmetic ingredient labelling is mandatory within the European Union. METHODS: We conducted a retrospective review of the patch test records of all patients with eczema who underwent testing using the European baseline series, extended with the individual fragrance substances during the period from 2015 to 2016. RESULTS: Overall, 359 patients (17·2%) reacted to one or more allergens from the labelled fragrance substance series and/or a fragrance marker from the European baseline series. The allergens that were positive with the greatest frequencies were oxidized linalool [n = 154; 7·4%, 95% confidence interval (CI) 6·3-8·6], oxidized limonene (n = 89; 4·3%, 95% CI 3·4-5·2) and Evernia furfuracea (n = 44; 2·1%, 95% CI 1·5-2·8). Of the 319 patients who reacted to any of the labelled fragrance substances, only 130 (40·8%) also reacted to a baseline series fragrance marker. The sensitivity of our history-taking for detecting fragrance allergy was 25·7%. CONCLUSIONS: Given the evolving trends in fragrance allergy, patch testing with FMI, FMII, M. pereirae and hydroxyisohexyl 3-cyclohexene carboxaldehyde is no longer sufficient for screening for fragrance allergy.
引用
- Ung CY, White JML, White IR, et al. Patch testing with the European baseline series fragrance markers: a 2016 update. Br J Dermatol. 2018. PMID: 28960261. doi:10.1111/bjd.15949
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。